Literature DB >> 29797184

Cellular Trafficking of Amyloid Precursor Protein in Amyloidogenesis Physiological and Pathological Significance.

Noralyn Basco Mañucat-Tan1, Khalil Saadipour2, Yan-Jiang Wang3, Larisa Bobrovskaya4, Xin-Fu Zhou5.   

Abstract

The accumulation of excess intracellular or extracellular amyloid beta (Aβ) is one of the key pathological events in Alzheimer's disease (AD). Aβ is generated from the cleavage of amyloid precursor protein (APP) by beta secretase-1 (BACE1) and gamma secretase (γ-secretase) within the cells. The endocytic trafficking of APP facilitates amyloidogenesis while at the cell surface, APP is predominantly processed in a non-amyloidogenic manner. Several adaptor proteins bind to both APP and BACE1, regulating their trafficking and recycling along the secretory and endocytic pathways. The phosphorylation of APP at Thr668 and BACE1 at Ser498, also influence their trafficking. Neurotrophins and proneurotrophins also influence APP trafficking through their receptors. In this review, we describe the molecular trafficking pathways of APP and BACE1 that lead to Aβ generation, the involvement of different signaling molecules or adaptor proteins regulating APP and BACE1 subcellular localization. We have also discussed how neurotrophins could modulate amyloidogenesis through their receptors.

Entities:  

Keywords:  APP; Amyloidogenesis; BACE1; Cellular trafficking; Gamma-secretase

Mesh:

Substances:

Year:  2018        PMID: 29797184     DOI: 10.1007/s12035-018-1106-9

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  172 in total

1.  Complete ablation of the neurotrophin receptor p75NTR causes defects both in the nervous and the vascular system.

Authors:  D von Schack; E Casademunt; R Schweigreiter; M Meyer; M Bibel; G Dechant
Journal:  Nat Neurosci       Date:  2001-10       Impact factor: 24.884

Review 2.  Ectodomain shedding of the amyloid precursor protein: cellular control mechanisms and novel modifiers.

Authors:  Stefan F Lichtenthaler
Journal:  Neurodegener Dis       Date:  2006       Impact factor: 2.977

3.  APP and APLP2 are essential at PNS and CNS synapses for transmission, spatial learning and LTP.

Authors:  Sascha W Weyer; Maja Klevanski; Andrea Delekate; Vootele Voikar; Dorothee Aydin; Meike Hick; Mikhail Filippov; Natalia Drost; Kristin L Schaller; Martina Saar; Miriam A Vogt; Peter Gass; Ayan Samanta; Andres Jäschke; Martin Korte; David P Wolfer; John H Caldwell; Ulrike C Müller
Journal:  EMBO J       Date:  2011-04-26       Impact factor: 11.598

4.  Interaction of Tau with Fe65 links tau to APP.

Authors:  Christian Barbato; Nadia Canu; Nicola Zambrano; Annalucia Serafino; Giuseppina Minopoli; Maria Teresa Ciotti; Giuseppina Amadoro; Tommaso Russo; Pietro Calissano
Journal:  Neurobiol Dis       Date:  2005-03       Impact factor: 5.996

5.  Low affinity nerve growth factor receptor binding in normal and Alzheimer's disease basal forebrain.

Authors:  J J Treanor; D Dawbarn; S J Allen; S H MacGowan; G K Wilcock
Journal:  Neurosci Lett       Date:  1991-01-02       Impact factor: 3.046

6.  2016 Alzheimer's disease facts and figures.

Authors: 
Journal:  Alzheimers Dement       Date:  2016-04       Impact factor: 21.566

Review 7.  Neurotrophin secretion: current facts and future prospects.

Authors:  Volkmar Lessmann; Kurt Gottmann; Marzia Malcangio
Journal:  Prog Neurobiol       Date:  2003-04       Impact factor: 11.685

8.  A Pro-Nerve Growth Factor (proNGF) and NGF Binding Protein, α2-Macroglobulin, Differentially Regulates p75 and TrkA Receptors and Is Relevant to Neurodegeneration Ex Vivo and In Vivo.

Authors:  Pablo F Barcelona; H Uri Saragovi
Journal:  Mol Cell Biol       Date:  2015-07-27       Impact factor: 4.272

Review 9.  Gamma Secretase Modulators: New Alzheimer's Drugs on the Horizon?

Authors:  Matthew G Bursavich; Bryce A Harrison; Jean-François Blain
Journal:  J Med Chem       Date:  2016-04-05       Impact factor: 7.446

10.  New Insights to Clathrin and Adaptor Protein 2 for the Design and Development of Therapeutic Strategies.

Authors:  Ebbe Toftgaard Poulsen; Agnete Larsen; Alen Zollo; Arne L Jørgensen; Kristian W Sanggaard; Jan J Enghild; Carmela Matrone
Journal:  Int J Mol Sci       Date:  2015-12-10       Impact factor: 5.923

View more
  8 in total

Review 1.  Pharmacological modulation of autophagy for Alzheimer's disease therapy: Opportunities and obstacles.

Authors:  Zhiqiang Deng; Yu Dong; Xiaoting Zhou; Jia-Hong Lu; Zhenyu Yue
Journal:  Acta Pharm Sin B       Date:  2021-12-18       Impact factor: 14.903

2.  Alzheimer's Disease "Non-amyloidogenic" p3 Peptide Revisited: A Case for Amyloid-α.

Authors:  Ariel J Kuhn; Benjamin S Abrams; Stella Knowlton; Jevgenij A Raskatov
Journal:  ACS Chem Neurosci       Date:  2020-05-22       Impact factor: 4.418

3.  TrkB receptor cleavage by delta-secretase abolishes its phosphorylation of APP, aggravating Alzheimer's disease pathologies.

Authors:  Yiyuan Xia; Zhi-Hao Wang; Pai Liu; Laura Edgington-Mitchell; Xia Liu; Xiao-Chuan Wang; Keqiang Ye
Journal:  Mol Psychiatry       Date:  2020-08-11       Impact factor: 15.992

4.  In vivo induction of membrane damage by β-amyloid peptide oligomers.

Authors:  Carl Julien; Colson Tomberlin; Christine M Roberts; Aumbreen Akram; Gretchen H Stein; Michael A Silverman; Christopher D Link
Journal:  Acta Neuropathol Commun       Date:  2018-11-29       Impact factor: 7.801

Review 5.  Protective genes and pathways in Alzheimer's disease: moving towards precision interventions.

Authors:  Mabel Seto; Rebecca L Weiner; Logan Dumitrescu; Timothy J Hohman
Journal:  Mol Neurodegener       Date:  2021-04-29       Impact factor: 14.195

Review 6.  Brain-derived neurotrophic factor in Alzheimer's disease and its pharmaceutical potential.

Authors:  Lina Gao; Yun Zhang; Keenan Sterling; Weihong Song
Journal:  Transl Neurodegener       Date:  2022-01-28       Impact factor: 8.014

7.  SPIN90 Deficiency Ameliorates Amyloid β Accumulation by Regulating APP Trafficking in AD Model Mice.

Authors:  Youngsoo Oh; Wongyoung Lee; So Hee Kim; Sooji Lee; Byeong C Kim; Kun Ho Lee; Sung Hyun Kim; Woo Keun Song
Journal:  Int J Mol Sci       Date:  2022-09-12       Impact factor: 6.208

8.  Post-Translational Modifications of BACE1 in Alzheimer's Disease.

Authors:  Wen Wen; Ping Li; Panwang Liu; Shijun Xu; Fushun Wang; Jason H Huang
Journal:  Curr Neuropharmacol       Date:  2022       Impact factor: 7.708

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.